itraconazole and Arachnoidal Cerebellar Sarcoma, Circumscribed

itraconazole has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aftab, BT; Beachy, PA; Borodovsky, A; Chen, B; Epstein, EH; Kim, D; Kim, J; King, EM; Lee, AH; Rezaee, M; Riggins, GJ; Rudin, CM; Tang, JY	1

Other Studies

1 other study(ies) available for itraconazole and Arachnoidal Cerebellar Sarcoma, Circumscribed

Article	Year
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer cell, 2013, Jan-14, Volume: 23, Issue:1 Topics: Anilides; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Hedgehog Proteins; Itraconazole; Medulloblastoma; Mice; Oxides; Pyridines; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor	2013

Article

Year

Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.

Cancer cell, 2013, Jan-14, Volume: 23, Issue:1

Topics: Anilides; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Hedgehog Proteins; Itraconazole; Medulloblastoma; Mice; Oxides; Pyridines; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor

2013